JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258611

Human PTGER3 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

PTGER3 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon1 and 1 bp insertion in exon1 and Insertion of the selection cassette in exon1.

View Alternative Names

EP 3, EP3 I, EP3 II, EP3 III, EP3 IV, EP3 subtype, EP3e, Ep3 prostanoid receptor, Ep3 receptor, HGNC:9595, MGC141828, MGC141829, MGC27302, PE2R3_HUMAN, PGE receptor EP3 subtype, PGE2 receptor EP3 subtype, PGE2-R, Pgerep3, Prostaglandin E receptor 3, Prostaglandin E receptor 3 (subtype EP3), Prostaglandin E receptor EP3 subtype 3 isoform, Prostaglandin E2 receptor, Prostaglandin E2 receptor EP3 subtype, Prostaglandin e2 receptor ep3, Prostaglandin receptor (PGE 2), Prostaglandin receptor 3, EP3, subtype, Prostanoid EP3 receptor, Ptgerep3, Rep3, rEP3a, rEP3b

3 Images
Sanger Sequencing - Human PTGER3 knockout HeLa cell lysate (AB258611)
  • Sanger seq

Unknown

Sanger Sequencing - Human PTGER3 knockout HeLa cell lysate (AB258611)

Allele-3 : Insertion of the selection cassette in exon1

Sanger Sequencing - Human PTGER3 knockout HeLa cell lysate (AB258611)
  • Sanger seq

Unknown

Sanger Sequencing - Human PTGER3 knockout HeLa cell lysate (AB258611)

Allele-1 : 11 bp deletion in exon1

Sanger Sequencing - Human PTGER3 knockout HeLa cell lysate (AB258611)
  • Sanger seq

Unknown

Sanger Sequencing - Human PTGER3 knockout HeLa cell lysate (AB258611)

Allele-2 : 1 bp insertion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon1 and 1 bp insertion in exon1 and Insertion of the selection cassette in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258611-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human PTGER3 knockout HeLa cell lysate", "number":"AB258611-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258611-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
PTGER3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The PTGER3 protein also known as the prostaglandin E2 receptor EP3 subtype is a G-protein coupled receptor (GPCR) with a molecular weight of approximately 53 kDa. This receptor binds prostaglandin E2 (PGE2) and modulates various physiological responses by activating different second messenger systems. PTGER3 exhibits diverse expression patterns being present in tissues such as the smooth muscle kidney uterus neural tissues and certain immune cells. Its expression in various tissues suggests its involvement in multiple functions that rely on PGE2 signaling.
Biological function summary

PTGER3 involves itself in mediating the effects of prostaglandin E2 through the inhibition of adenylate cyclase and the modulation of intracellular calcium levels. It does not operate as part of a larger protein complex but functions independently as a receptor. This receptor's activity influences processes such as smooth muscle contraction regulation of body temperature and modulation of hormone release. The variation in signaling allows PTGER3 to have a broad impact on physiological processes adapting its functions based on tissue and cellular context.

Pathways

PTGER3 is part of the prostaglandin signaling pathway and participates in cAMP signaling. It interacts with G-proteins that act as intermediates to modulate adenylate cyclase activity and control cyclic AMP production. The receptor acts in a network with other prostaglandin receptors such as PTGER1 PTGER2 and PTGER4 coordinating responses to PGE2 by either amplifying or opposing their effects depending on the cellular environment. Such interactions position PTGER3 at the junction of pathways critical for homeostatic control and adaptive responses.

PTGER3 has connections to several conditions including inflammatory diseases and hypertension. Inflammatory diseases such as rheumatoid arthritis show altered PGE2 signaling pathways where PTGER3 plays a role in mediating inflammation and immune responses. Its activity is also implicated in regulating blood pressure by influencing vascular smooth muscle contraction. Additionally its function intersects with proteins like COX-2 which is involved in PGE2 biosynthesis indicating a broader role in maintaining homeostasis within disease contexts.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com